Comoros vs South Africa: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Comoros
1.0%
in 2024
South Africa
1.0%
in 2024
Comoros rank
34th
South Africa rank
34th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Comoros
- South Africa
How they compare
Comoros currently reports 1.0% against 1.0% in South Africa, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Comoros ahead.
Comoros ranks 34th and South Africa ranks 34th of 246 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Comoros | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.3% | 1.3% | 0.0% | South Africa |
| 2020s | 0.9% | 1.1% | 0.2% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Comoros or South Africa?
- Comoros, at 1.0% against 1.0% in South Africa as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Comoros and South Africa?
- 0.0%, with Comoros ahead.
- How many years of comparable data are there for Comoros and South Africa?
- 10 years are reported by both, from 2015 to 2024.
- How do Comoros and South Africa rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Comoros ranks 34th and South Africa ranks 34th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.